Concord Asset Management, Llc/Va Regeneron Pharmaceuticals, Inc. Transaction History
Concord Asset Management, Llc/Va
- $454 Billion
- Q1 2025
A detailed history of Concord Asset Management, Llc/Va transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Concord Asset Management, Llc/Va holds 2,259 shares of REGN stock, worth $1.11 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
2,259
Previous 1,287
75.52%
Holding current value
$1.11 Million
Previous $917 Million
44.85%
% of portfolio
0.29%
Previous 0.2%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,471Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.61 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.14 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.77 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.35 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$1.96 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $52.6B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...